GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (STU:26CA) » Definitions » Investments And Advances

ImmunityBio (STU:26CA) Investments And Advances : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Investments And Advances?

ImmunityBio's Investments And Advances for the quarter that ended in Mar. 2024 was €0.00 Mil.

ImmunityBio's quarterly Investments And Advances increased from Sep. 2023 (€0.77 Mil) to Dec. 2023 (€0.82 Mil) but then declined from Dec. 2023 (€0.82 Mil) to Mar. 2024 (€0.00 Mil).

ImmunityBio's annual Investments And Advances declined from Dec. 2021 (€6.72 Mil) to Dec. 2022 (€0.79 Mil) but then increased from Dec. 2022 (€0.79 Mil) to Dec. 2023 (€0.82 Mil).


ImmunityBio Investments And Advances Historical Data

The historical data trend for ImmunityBio's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Investments And Advances Chart

ImmunityBio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
- 9.37 6.72 0.79 0.82

ImmunityBio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.78 0.77 0.82 -

ImmunityBio Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


ImmunityBio (STU:26CA) Business Description

Traded in Other Exchanges
Address
3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

ImmunityBio (STU:26CA) Headlines

No Headlines